Next Generation Gene Therapeutics (NGGT) Announces Publication of Early Clinical Trial Results for NGGT001 for the Treatment of Bietti’s Crystalline Dystrophy (BCD)

Posted on by

Results from dose-escalation study show safety and preliminary efficacy signal of NGGT001 for the treatment of BCD WALNUT CREEK, Calif., Jan. 14, 2025 /PRNewswire/ — NGGT Inc., (“Next Generation Gene Therapeutics” or “NGGT” or the “Company”), a clinical-stage biotechnology company…

Posted in UncategorizedTagged
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.